Marcy l’Etoile (France) - December 14, 2011. At the request of the French “Autorité des Marchés Financiers”, bioMérieux, a world leader in the field of in vitro diagnostics, completes the information in its December 7th press release on its 2011 sales objective, specifying that it has not changed the 2011 objective for operating income before non-recurring items that was previously announced.
The above forward-looking statements are based, entirely or partially, on assessments or judgments that may change or be modified, due to uncertainties and risks related to the Company's economic, financial, regulatory and competitive environment, notably those described in the 2010 Registration Document. Accordingly, the Company cannot give any assurance nor make any representation as to whether the above objectives will be met. The Company does not undertake to update or otherwise revise any forecasts or objectives presented herein, except in compliance with the disclosure obligations applicable to companies whose shares are listed on a stock exchange.